Secondary Logo

March/April 2019 - Volume 39 - Issue 2

  • Richard I. Shader, MD
    David J. Greenblatt, MD
  • 0271-0749
  • 1533-712X
  • 6 issues / year
  • Psychiatry 50/142; Pharmacy and Pharmacology 85/261
  • 3.134

Current Issue Highlights




Twenty-Four–Hour Measures of Heart Rate–Corrected QT Interval, Peak-to-End of the T-Wave, and Peak-to-End of the T-Wave/Corrected QT Interval Ratio During Antipsychotic Treatment

Tümüklü, Mevhibe N.; Tümüklü, Mustafa M.; Nesterenko, Vladislav; More

Journal of Clinical Psychopharmacology. 39(2):100-107, March/April 2019.



Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial

Evins, A. Eden; Benowitz, Neal L.; West, Robert; More

Journal of Clinical Psychopharmacology. 39(2):108-116, March/April 2019.